Concepedia
Statistics
Publications
18
Citations
756
H-Index
13
Active since
1995
Affiliations
Ability Pharmaceuticals (Spain)(Current)
Universitat Autònoma de Barcelona
Vall d'Hebron Hospital Universitari
Vall d'Hebron Institut de Recerca
Vall d'Hebron Institute of Oncology
José Alfón is an author at Ability Pharmaceuticals (Spain) specializing in pharmacology, medicine, and oncology.
Publications per year
1995–2024
Synthesis and Structure−Activity Relationship of a New Series of COX-2 Selective Inhibitors: 1,5-Diarylimidazoles
Carmen Almansa, José Alfón, Alberto Fernández de Arriba et al. · Journal of Medicinal Chemistry · 2003 · 134 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells
Pau Muñoz‐Guardiola, Josefina Casas, Elisabet Megías‐Roda et al. · Autophagy · 2020 · 113 citations · Full text
Life Sciences, Oncology, Pharmacology +17
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase
Tatiana Erazo, Mar Lorente, Anna López‐Plana et al. · Clinical Cancer Research · 2015 · 74 citations · Full text
Medicine, Oncology, Pharmacology +17
HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels
José Martínez‐González, José Alfón, M. Berrozpe et al. · Atherosclerosis · 2001 · 65 citations
Life Sciences, Biochemistry, Pharmacology +11
Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors
José Alfón, Joan Francesc Guasch, M. Berrozpe et al. · Atherosclerosis · 1999 · 56 citations
Life Sciences, Cardiology, Molecular Biology +11
1–5 of 18